Press Releases

Date Title and Summary
Toggle Summary Beverly A. Huss Joins Accuray Board of Directors
SUNNYVALE, Calif. , Jan. 11, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company's Board of Directors, effective January 7, 2018 . Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc. , Surefire Medical, Inc.
Toggle Summary Accuray To Report Fiscal 2018 Second Quarter Financial Results On January 23, 2018
SUNNYVALE, Calif. , Jan. 10, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2017 on Tuesday, January 23, 2018 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray Elects Net Share Settlement for 3.50% Series A Convertible Senior Notes Due 2018
Company will pay principal in cash and deliver shares for any excess conversion value SUNNYVALE, Calif. , Jan. 3, 2018 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) has made an irrevocable Net Share Settlement Election with respect to its 3.50% Series A Convertible Senior Notes due February
Toggle Summary Accuray to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 10, 2018
SUNNYVALE, Calif. , Jan. 3, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at the J.P. Morgan 36th Annual Healthcare Conference on Wednesday, January 10, 2018 at the Westin St. Francis Hotel in San Francisco .
Toggle Summary Accuray Enters into $40 Million Term Loan; Company Intends to Retire Principal Amount of February 2018 Convertible Notes with Cash at Maturity
Company Also Modifies Revolving Loan Agreement SUNNYVALE, Calif. , Dec. 21, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it closed a new $40 million term loan with MidCap Financial Trust while concurrently reducing the borrowing facility under its existing revolving
Toggle Summary First Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
iDMS™ Data Management System Helps Improve Treatment Outcomes and Efficiency by Sharing Patient Data Throughout the Entire Disease Management Period SUNNYVALE, Calif. , Dec. 14, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Heidelberg University Hospital in
Toggle Summary Accuray Military Veterans Support U.S. Veteran Community
Advanced Radiation Therapy Systems Manufactured, Installed and Serviced by Accuray Veterans Help Improve the Lives of Military Personnel who are Diagnosed with Cancer SUNNYVALE, Calif. , Nov. 8, 2017 /PRNewswire/ -- November 11, 2017 marks Veterans Day in the United States , a day to publicly
Toggle Summary Treatment Planning for the CyberKnife® System Now Up to 40% Faster
- Accuray Precision™ Treatment Planning System and CyberKnife System Software Upgrade Enhances Efficiency and Ease-of-Use - Leading Radiation Oncology Providers at Institut Gustave Roussy, Lynn Cancer Institute, Multicare Hospital, Queen Elizabeth Hospital Birmingham, University Clinic for
Toggle Summary Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year
SUNNYVALE, Calif. , Oct. 24, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first fiscal quarter ended September 30, 2017 . First Quarter Highlights Gross orders increased 11 percent to $55.6 million , net orders were $51.0 million .
Toggle Summary European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System
SUNNYVALE, Calif. , Oct. 19, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System by University Hospital of Tours (CHU).